As per the recently published report by MarketsandMarkets™, The report "Hemodialysis and Peritoneal Dialysis Market by Product (Machine, Bloodline, Concentrate (Alkaline), Catheter, Dialyzer, Water Treatment, Services), Modality (CAPD, Nocturnal), User (Hospital, Home Care) - Global Forecast to 2029", is projected to reach USD 126.2 billion by 2029 from USD 92.0 billion in 2024 at a CAGR of 6.5% during the forecast period.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1279

Browse
• 150 Market Data Tables
• 65 Figures
• 350 Pages and in-depth TOC on " Hemodialysis and Peritoneal Dialysis Market - Global Forecast to 2029”

Some of the prominent key players are:
• Fresenius Medical Care AG & Co. KGaA (Germany),
• Baxter International Inc. (US),
• Nipro Corporation (Japan),
• NIKKISO CO., LTD. (Japan), and many more......

Mergers & acquisitions, investments & expansions, partnerships & collaborations, and new product developments are some of the major strategies adopted by these key players to enhance their positions in the Hemodialysis and Peritoneal Dialysis Market .

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=1279
• The hemodialysis market is segmented based on product and service. Hemodialysis products include hemodialysis machines and hemodialysis consumables & supplies, whereas hemodialysis services include in-center services and home services. The hemodialysis services segment is anticipated to grow at significant rate during the forecast period.
• Based on end users, home care setting is expected to grow at a significant rate owing to growing preference of patients for home hemodialysis modality, technological advancements, and the cost-effectiveness of home dialysis treatment over incentre dialysis procedures.
• On the basis of region, the hemodialysis and peritoneal dialysis market is segmented into North America, Europe, Asia Pacific, and the Latin America, Middle East & Africa. The Asia-Pacific market is likely to witness significant market growth. This is attributed to the rise in geriatric patient population, increasing cases of chronic kidney diseases, moreover improving healthcare infrastructure and the implementation of supportive government initiatives to increase the accessibility of dialysis services in many APAC countries such as India and China.

The escalating global prevalence of chronic kidney disease, spurred by growing aging population coupled with the increasing cases of diabetes and hypertension are fuelling the demand for renal replacement therapy including hemodialysis and peritoneal dialysis products and services. Ongoing technological advancements in dialysis technology, growing patient preference of home dialysis, supporting reimbursement policies and government initiatives and funding for healthcare infrastructure, enabling expansion of hospitals and dialysis centers further enhancing the accessibility of hemodialysis and peritoneal dialysis services among patients with end-stage renal disease (ESRD) are likely to drive the market growth during the forecast period.